Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]

Pratik Chakraborty; Sabya Sachi Das; Abhijit Dey; Apala Chakraborty; Chiranjib Bhattacharyya; Ramesh Kandimalla; Biswajit Mukherjee; Abilash Valsala Gopalakrishnan; Sandeep Kumar Singh; Shubham Kant; Parma Nand; Shreesh Ojha; Pravir Kumar; Niraj Kumar Jha; Saurabh Kumar Jha; Saikat Dewanjee

doi:10.1016/j.jconrel.2022.10.033

Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]

Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, Apala Chakraborty, Chiranjib Bhattacharyya, Ramesh Kandimalla, Biswajit Mukherjee, Abilash Valsala Gopalakrishnan, Sandeep Kumar Singh, Shubham Kant, Parma Nand, Shreesh Ojha, Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Saikat Dewanjee

Department of Pharmacology and Therapeutics

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that in the original publication of this article the affiliations of the following authors Abhijit Dey, Biswajit Mukherjee, and Apala Chakraborty were incorrect. Their updated affiliations are as follows: Biswajit Mukherjee, and Apala Chakrabort have the following affiliation: c, Pharmaceutics Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Abhijit Dey has the following affiliation: d, Abhijit Dey, Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India. The authors apologize for any inconvenience caused.

Original language	English
Pages (from-to)	459
Number of pages	1
Journal	Journal of Controlled Release
Volume	352
DOIs	https://doi.org/10.1016/j.jconrel.2022.10.033
Publication status	Published - Dec 2022

ASJC Scopus subject areas

Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jconrel.2022.10.033

Fingerprint

Dive into the research topics of 'Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]'. Together they form a unique fingerprint.

Cite this

Chakraborty, P., Das, S. S., Dey, A., Chakraborty, A., Bhattacharyya, C., Kandimalla, R., Mukherjee, B., Gopalakrishnan, A. V., Singh, S. K., Kant, S., Nand, P., Ojha, S., Kumar, P., Jha, N. K., Jha, S. K., & Dewanjee, S. (2022). Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]. Journal of Controlled Release, 352, 459. https://doi.org/10.1016/j.jconrel.2022.10.033

Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]. / Chakraborty, Pratik; Das, Sabya Sachi; Dey, Abhijit et al.
In: Journal of Controlled Release, Vol. 352, 12.2022, p. 459.

Research output: Contribution to journal › Comment/debate › peer-review

Chakraborty, P, Das, SS, Dey, A, Chakraborty, A, Bhattacharyya, C, Kandimalla, R, Mukherjee, B, Gopalakrishnan, AV, Singh, SK, Kant, S, Nand, P, Ojha, S, Kumar, P, Jha, NK, Jha, SK & Dewanjee, S 2022, 'Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]', Journal of Controlled Release, vol. 352, pp. 459. https://doi.org/10.1016/j.jconrel.2022.10.033

Chakraborty P, Das SS, Dey A, Chakraborty A, Bhattacharyya C, Kandimalla R et al. Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]. Journal of Controlled Release. 2022 Dec;352:459. doi: 10.1016/j.jconrel.2022.10.033

@article{14211ed523eb45d7a0a100a26c026cd9,

title = "Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]",

abstract = "The authors regret that in the original publication of this article the affiliations of the following authors Abhijit Dey, Biswajit Mukherjee, and Apala Chakraborty were incorrect. Their updated affiliations are as follows: Biswajit Mukherjee, and Apala Chakrabort have the following affiliation: c, Pharmaceutics Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Abhijit Dey has the following affiliation: d, Abhijit Dey, Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India. The authors apologize for any inconvenience caused.",

author = "Pratik Chakraborty and Das, {Sabya Sachi} and Abhijit Dey and Apala Chakraborty and Chiranjib Bhattacharyya and Ramesh Kandimalla and Biswajit Mukherjee and Gopalakrishnan, {Abilash Valsala} and Singh, {Sandeep Kumar} and Shubham Kant and Parma Nand and Shreesh Ojha and Pravir Kumar and Jha, {Niraj Kumar} and Jha, {Saurabh Kumar} and Saikat Dewanjee",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier B.V.",

year = "2022",

month = dec,

doi = "10.1016/j.jconrel.2022.10.033",

language = "English",

volume = "352",

pages = "459",

journal = "Journal of Controlled Release",

issn = "0168-3659",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Corrigendum to “Quantum dots

T2 - The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]

AU - Chakraborty, Pratik

AU - Das, Sabya Sachi

AU - Dey, Abhijit

AU - Chakraborty, Apala

AU - Bhattacharyya, Chiranjib

AU - Kandimalla, Ramesh

AU - Mukherjee, Biswajit

AU - Gopalakrishnan, Abilash Valsala

AU - Singh, Sandeep Kumar

AU - Kant, Shubham

AU - Nand, Parma

AU - Ojha, Shreesh

AU - Kumar, Pravir

AU - Jha, Niraj Kumar

AU - Jha, Saurabh Kumar

AU - Dewanjee, Saikat

PY - 2022/12

Y1 - 2022/12

N2 - The authors regret that in the original publication of this article the affiliations of the following authors Abhijit Dey, Biswajit Mukherjee, and Apala Chakraborty were incorrect. Their updated affiliations are as follows: Biswajit Mukherjee, and Apala Chakrabort have the following affiliation: c, Pharmaceutics Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Abhijit Dey has the following affiliation: d, Abhijit Dey, Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India. The authors apologize for any inconvenience caused.

AB - The authors regret that in the original publication of this article the affiliations of the following authors Abhijit Dey, Biswajit Mukherjee, and Apala Chakraborty were incorrect. Their updated affiliations are as follows: Biswajit Mukherjee, and Apala Chakrabort have the following affiliation: c, Pharmaceutics Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Abhijit Dey has the following affiliation: d, Abhijit Dey, Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India. The authors apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85142417983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142417983&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2022.10.033

DO - 10.1016/j.jconrel.2022.10.033

M3 - Comment/debate

C2 - 36332496

AN - SCOPUS:85142417983

SN - 0168-3659

VL - 352

SP - 459

JO - Journal of Controlled Release

JF - Journal of Controlled Release

ER -

Corrigendum to “Quantum dots: The cutting-edge nanotheranostics in brain cancer management” [Journal of Controlled Release, Volume 350 (2022) Pages 698–715, (S0168365922005545), (10.1016/j.jconrel.2022.08.047)]

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this